Navigation Links
PTS, Inc. Signs Agreement to Provide Point-of-Care Lipid Testing to Life Line Screening
Date:9/6/2012

INDIANAPOLIS, Sept. 6, 2012 /PRNewswire/ -- Polymer Technology Systems, Inc. (PTS), the U.S.- based manufacturer of the CardioChek family of point-of-care diagnostic products, has announced the signing of a multiyear agreement to supply the CardioChek PA test system to Life Line Screening, a leading global provider of community-based preventive health screenings.

The CardioChek test system provides on-site lipid panel screening, which includes total cholesterol, HDL cholesterol, triglycerides, and LDL (calculated), as well as glucose, and delivers the results in less than two minutes.

According to Life Line Screening's Laboratory Medical Director, Benjamin Gerson, MD, "PTS is an ideal partner for us. Life Line Screening is certified under the CLIA federal mandate with a Certificate of Compliance, and as such, our focus is on quality. We have 60 community-based teams throughout the U.S., conducting approximately 15,000 health screening events a year. The CardioChek system does not require a venous draw, allowing us to deliver fast results so our teams can provide clients with immediate feedback."

Robert Huffstodt, President and CEO of PTS, Inc., is equally excited about the partnership. "Life Line Screening is a cutting-edge screening provider in the U.S. and abroad, and we are proud to have them implement our system around the world. They understand the role of preventive screening and have created a model that can deliver services on a global scale. This is very impressive and makes them a unique partner." The ability to use this system globally is an important component of this partnership. "CardioChek is in over 120 countries, by far the most in the business," said Kevin Luckow, Global Manager with Life Line Screening. "We are expanding our operations around the world, and they have the knowledge and experience in the intricacies of global business we need to grow."

Life Line Screening intends to deploy the CardioChek test system immediately. "PTS has the products, operational efficiencies, training, and distribution in place that we were looking for," continued Luckow. "Their system is accurate and easy to use.  It doesn't require refrigeration and is battery-operated, which are important operational benefits for our teams. We look forward to a long and mutually beneficial partnership."

The CardioChek test system, FDA-cleared for marketing in the U.S., in accordance with pre-market notification requirements set forth by the FDA, are CE-marked for marketing in the European Union and are licensed or registered as required for marketing globally.

About Life Line Screening
Life Line Screening was established in 1993, and has since become the nation's leading provider of preventive health screenings. Highly trained clinical teams are on staff across the nation to bring affordable screenings to convenient, neighborhood locations.  These non-invasive, painless tests help people identify their risk for stroke, vascular diseases or osteoporosis early enough that they and their physicians can begin preventive procedures. Visit the website at www.lifelinescreening.com or call 1-800-697-9177. 

About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in
Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world. The company has sales offices in Africa, Australia, Europe, Latin America, the Middle East and the Pacific Rim. PTS, Inc. products include the CardioChek® PA point-of-care instrument and the CardioChek® cholesterol analyzer that are marketed to the professional diagnostics industry and consumer screening market. The company offers tests for a Lipid Panel, LDL Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek PA point-of-care instrument and the CardioChek Health Risk Assessment (HRA) software. For more information, visit www.cardiochek.com

All trademarks used or mentioned in this release are protected by law.


'/>"/>
SOURCE Polymer Technology Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
2. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
3. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
4. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
5. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
6. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
7. Bacterin International Signs Its Third National GPO Contract with Novation
8. MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete
9. Masimo Signs Pronto-7™ Distribution Deal with Henry Schein
10. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
11. Wellness Center USA Inc. Signs Agreement to Acquire Psoria-Shield Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... , Feb. 4, 2016 Global Immunology ... market to drive long-term market growth Summary ... set of chronic disorders that affect 5–7% of ... terms of their symptoms and key patient demographics, ... of immune pathways and an inappropriate immune response. ...
(Date:2/4/2016)... SPRING, Md. , Feb. 4, 2016 In ... Califf , the FDA,s Deputy Commissioner for Medical Products and ... action plan to reassess the agency,s approach to opioid medications. ... epidemic, while still providing patients in pain access to effective ... The FDA will: , Re-examine the risk-benefit paradigm ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held last ... Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred ... Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served APDA ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Stuart ... tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. ... with unmatched results. , Developed by Cynosure, the PicoSure has been approved by the ...
(Date:2/5/2016)... ... February 05, 2016 , ... Colorize is ... one drop zone to the next using Colorize's dynamic moving camera. Colorize is perfect ... package includes a 3D slideshow environment with 1 to 5 focus points per scene, ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... ... 2016 , ... On June 9-10, Las Vegas will host ... (CME) event presented by the Association for Comprehensive Care in Rare Diseases (ACCORD). ... mission is to provide education, tools, and resources to primary care clinicians that ...
Breaking Medicine News(10 mins):